PCV13: Clinical Trials

4 trials of PCV13, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 unknown. 4 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 3, Unknown 1
Phase 22Completed 2

Follow PCV13: new trials by email Literature Review of PCV13 trials Research Report on PCV13

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I Clinical Trial of a Candidate PCV13 in Healthy People
13-Valent Pneumococcal Polysaccharide Conjugate Vaccine - Pneumococcal Infections
Phase 1UnknownWuhan BravoVax Co., Ltd.2642022-11-012022-11-17
A Study to Assess the Safety, Tolerability and Immunogenicity of ASP3772, a Pneumococcal Vaccine, in Toddlers 12 to 15 Months of Age in Comparison to an Active Comparator
ASP3772, PCV13 - Healthy Volunteers, Pneumococcal Disease
Phase 1CompletedAffinivax, Inc.752020-09-222022-06-06
A Single Ascending Dose Study in Adults (Stage 1) and Single Ascending Dose-Finding Study (Stage 2) in Elderly Subjects With ASP3772, A Pneumococcal Vaccine
ASP3772, PCV13, PPSV23 - Pneumonia, Bacterial, Healthy Volunteers
Phase 1 / Phase 2CompletedGlaxoSmithKline6302019-01-242023-12-21
Activated White Blood Cells With ASCT for Newly Diagnosed Multiple Myeloma
MILs, Melphalan, PCV13 - Multiple Myeloma and Plasma Cell Neoplasm
Phase 1 / Phase 2CompletedSidney Kimmel Comprehensive Cancer Center at Johns Hopkins262007-11-012023-05-26

Conditions studied

Pneumococcal Infections (3)  ·  Multiple Myeloma (1)  ·  Neoplasms, Plasma Cell (1)  ·  Pneumonia, Bacterial (1)  ·  Pneumonia, Pneumococcal (1)

Sponsors

Affinivax, Inc. (1)  ·  GlaxoSmithKline (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)  ·  Wuhan BravoVax Co., Ltd. (1)

Countries

United States (3)  ·  China (1)

Top investigators

Ivan Borrello, MD (1)

Results publications

PMID 25995224, PMID 35690500, PMID 38360475

NIH funding

2019 (1), P30CA006973 (1)